Global Cord Blood (NYSE:CO) Stock Price Crosses Above 200-Day Moving Average - Time to Sell?

Key Points

• Global Cord Blood (NYSE: CO) crossed above its 200-day moving average, trading as high as $0.9505 (200-day MA $0.92) on light volume of 250 shares and was up about 0.1%.
• The company has a market cap of $115.53 million, a PE ratio of 1.49 and a beta of 0.16, and operates leading umbilical cord blood banking and related clinical services in China, including collection, processing, testing and long-term storage of stem cells.

Global Cord Blood Co. (NYSE:CO - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.92 and traded as high as $0.9505. Global Cord Blood shares last traded at $0.9505, with a volume of 250 shares trading hands.

Global Cord Blood Stock Up 0.1%

The firm's 50-day moving average is $0.99 and its 200-day moving average is $0.92. The company has a market cap of $115.53 million, a PE ratio of 1.49 and a beta of 0.16.

Global Cord Blood Company Profile

Global Cord Blood Corporation NYSE: CO is a leading operator of umbilical cord blood banking services in the People's Republic of China. The company provides critical stem cell preservation and related services through its network of cord blood banks and medical partners. Its core activities encompass the collection, processing, testing, and long-term storage of cord blood units, which are preserved for potential therapeutic use in the treatment of hematological and genetic disorders.

In addition to cord blood banking, Global Cord Blood offers supplemental clinical services such as viability testing, stem cell expansion research, and personalized consultation for expectant parents.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.